MoneyLion (ML) 10-K/A 6 May 21 2020 FY Annual report (amended) Financial data

Document And Entity Information

Document And Entity Information - USD ($)	10 Months Ended
	Dec. 31, 2020	Mar. 25, 2021	Jun. 30, 2020
Document Information Line Items
Entity Registrant Name	Fusion Acquisition Corp.
Document Type	10-K/A
Current Fiscal Year End Date	--12-31
Entity Public Float			$ 355,600,000
Amendment Flag	true
Amendment Description	This Annual Report on Form 10-K/A (“Form 10-K/A”) is being filed as Amendment No. 1 (the “Amendment”) to our Annual Report on Form 10-K for the period ended December 31, 2020, which was filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 25, 2021 (the “Original 10-K”). This Form 10-K/A is being filed to restate the balance sheet, statement of operations, statement of changes in stockholders’ equity and statement of cash flows as of December 31, 2020 and for the period from March 6, 2020 (inception) through December 31, 2020.On April 12, 2021, the staff of the Securities and Exchange Commission (the “SEC Staff”) issued a public statement entitled “Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”) (the “SEC Staff Statement”). In the SEC Staff Statement, the SEC Staff expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities on the SPAC’s balance sheet as opposed to being treated as equity. Since their issuance on June 30, 2020 at the time of the Company’s initial public offering, our warrants were accounted for as equity within our balance sheet, and after discussion and evaluation, including with our independent auditors, we have concluded that our warrants should be presented as liabilities with subsequent fair value remeasurement.Historically, our warrants were reflected as a component of equity as opposed to liabilities on the balance sheet and the statement of operations did not include the subsequent non-cash changes in estimated fair value of our warrants, based on our application of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 815-40, Derivatives and Hedging, Contracts in Entity’s Own Equity (“ASC 815-40”). The views expressed in the SEC Staff Statement were not consistent with the Company’s historical interpretation of the specific provisions within its warrant agreement and the Company’s application of ASC 815-40 to the warrant agreement. We reassessed our accounting for our warrants issued on June 30, 2020, in light of the SEC Staff’s published views. Based on this reassessment, we determined that our warrants should be classified as liabilities measured at fair value upon issuance, with subsequent changes in fair value reported in our Statement of Operations each reporting period.The effects of this restatement to our financial statements are described in Note 2 to the financial statements. The following sections have been amended from the Original 10-K as a result of the restatement described above:   ● Part I – Item 1A. Risk Factors   ● Part I - Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations ●Part I - Item 8. Financial Statements and Supplementary Data ●Part II – Item 9A. Controls and ProceduresIn connection with the restatement, the Company’s management reassessed the effectiveness of its disclosure controls and procedures for the periods affected by the restatement. As a result of that reassessment, the Company’s management determined that its disclosure controls and procedures for such periods were not effective with respect to the classification of the Company’s warrants as components of equity instead of as derivative liabilities. For more information, see Item 9A included in this Annual Report on Form 10-K/A.The Company has not amended its previously filed Quarterly Reports on Form 10-Q for the periods affected by the restatement. The financial information that has been previously filed or otherwise reported for these periods is superseded by the information in this Annual Report on Form 10-K/A, and the financial statements and related financial information contained in such previously filed reports should no longer be relied upon. This Form 10-K/A also includes as exhibits certifications from our Chief Executive Officer and Chief Financial Officer dated as of the date of this filing. Except as described above, no other sections have been amended from the Original 10-K.
Entity Central Index Key	0001807846
Entity Current Reporting Status	No
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
Document Transition Report	false
Entity File Number	001-39346
Entity Incorporation, State or Country Code	DE
Entity Interactive Data Current	No
Class A Common Stock
Document Information Line Items
Entity Common Stock, Shares Outstanding		35,000,000
Class B Common Stock
Document Information Line Items
Entity Common Stock, Shares Outstanding		8,750,000

Balance Sheet

Balance Sheet	Dec. 31, 2020USD ($)
Current assets
Cash	$ 950,537
Prepaid expenses	113,562
Total Current Assets	1,064,099
Security deposit	329
Marketable securities held in trust account	350,219,336
Total Assets	351,283,764
Current liabilities
Accounts payable and accrued expenses	239,531
Income tax payable	11,509
Total Current Liabilities	251,040
Deferred underwriting fee payable	13,150,000
Derivative warrant liability	66,126,490
Total Liabilities	79,527,530
Commitments and contingencies
Class A common stock subject to possible redemption, 26,675,623 shares at $10.00 per share redemption value	266,756,230
Stockholders’ Equity
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Additional paid-in capital	44,267,476
Accumulated deficit	(39,269,179)
Total Stockholders’ Equity	5,000,004
Total Liabilities and Stockholders’ Equity	351,283,764
Class A Common Stock
Stockholders’ Equity
Common stock value	832
Total Stockholders’ Equity	832
Class B Common Stock
Stockholders’ Equity
Common stock value	875
Total Stockholders’ Equity	$ 875

Balance Sheet (Parentheticals)

Balance Sheet (Parentheticals)	Dec. 31, 2020$ / sharesshares
Preferred stock par value (in Dollars per share) | $ / shares	$ 0.0001
Preferred stock, shares authorized	1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Class A Common Stock
Class A common stock, subject to possible redemption, Price per share (in Dollars per share) | $ / shares	$ 10
Common stock subject to possible redemption	26,675,623
Common stock, par value (in Dollars per share) | $ / shares	$ 0.0001
Common stock, shares authorized	380,000,000
Common stock, shares issued	8,324,377
Common stock, shares outstanding	1,711,728
Class B Common Stock
Common stock, par value (in Dollars per share) | $ / shares	$ 0.0001
Common stock, shares authorized	20,000,000
Common stock, shares issued	8,750,000
Common stock, shares outstanding	8,750,000

Statement of Operations

Statement of Operations	10 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Income Statement [Abstract]
Formation and operating costs	$ 1,167,417
Loss from operations	(1,167,417)
Change in fair value of public warrant liability	(25,725,000)
Change in fair value of private placement warrant liability	(12,584,590)
Interest earned on investments held in Trust Account	219,337
Loss before provision for income taxes	(39,257,670)
Provision for income taxes	(11,509)
Net loss	$ (39,269,179)
Weighted average shares outstanding of Class A redeemable common stock (in Shares) | shares	35,000,000
Basic and diluted income per share, Class A redeemable common stock (in Dollars per share) | $ / shares	$ 0
Weighted average shares outstanding of Class B non-redeemable common stock (in Shares) | shares	8,750,000
Basic and diluted net loss per share, Class B non-redeemable common stock (in Dollars per share) | $ / shares	$ (4.49)

Statement of Changes in Stockho

Statement of Changes in Stockholders’ Equity - 10 months ended Dec. 31, 2020 - USD ($)	Class A Common Stock	Class B Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Mar. 05, 2020
Balance (in Shares) at Mar. 05, 2020
Issuance of Class B common stock to Sponsor		$ 877	24,123		25,000
Issuance of Class B common stock to Sponsor (in Shares)
Sale of 35,000,000 Units, net of underwriting discounts, offering costs and derivative liabilities for public warrants	$ 3,500		310,996,913		311,000,413
Sale of 35,000,000 Units, net of underwriting discounts, offering costs and derivative liabilities for public warrants (in Shares)	35,000,000
Sale of 8,100,000 private placement warrants
Forfeiture of Founder Shares		$ (2)	2
Forfeiture of Founder Shares (in Shares)		(18,750)
Class A common stock subject to possible redemption	$ (2,668)		(266,753,562)		(266,756,230)
Class A common stock subject to possible redemption (in Shares)	(26,675,623)
Net loss				(39,269,179)	(39,269,179)
Balance at Dec. 31, 2020	$ 832	$ 875	$ 44,267,476	$ (39,269,179)	$ 5,000,004
Balance (in Shares) at Dec. 31, 2020	8,324,377	8,750,000

Statement of Changes in Stock_2

Statement of Changes in Stockholders’ Equity (Parentheticals)	10 Months Ended
	Dec. 31, 2020shares
Statement of Stockholders' Equity [Abstract]
Sale of units	35,000,000
Sale of private placement units	8,100,000

Statement of Cash Flows

Statement of Cash Flows - USD ($)	10 Months Ended
	Dec. 31, 2020
Cash Flows from Operating Activities:
Net loss	$ (39,269,179)
Interest earned on investments held in Trust Account	(219,337)
Change in fair value of derivative public warrant liabilities	25,725,000
Change in fair value of private placement warrant liability	12,584,590
Expenses allocated to operations from offering costs related to derivative warrant liability	551,352
Changes in operating assets and liabilities:
Prepaid expenses	(113,562)
Security deposit	(329)
Accounts payable and accrued expenses	239,532
Income taxes payable	11,509
Net cash used in operating activities	(490,424)
Cash Flows from Investing Activities:
Investment of cash into Trust Account	(350,000,000)
Net cash used in investing activities	(350,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	343,900,000
Proceeds from sale of Private Placement Warrants	8,100,000
Proceeds from promissory note – related party	32,378
Repayment of promissory note – related party	(186,165)
Payment of offering costs	(405,252)
Net cash provided by financing activities	351,440,961
Net Change in Cash	950,537
Cash – Beginning of period
Cash – End of period	950,537
Non-Cash financing activities:
Initial classification of Class A common stock subject to possible redemption	304,405,300
Change in value of Class A common stock subject to possible redemption	(37,649,070)
Deferred underwriting fee payable	13,150,000
Offering costs paid directly by Sponsor in consideration for the issuance of Class B common stock	25,000
Offering costs paid through promissory note – related party	153,787
Initial value of derivative warrant liabilities in connection with initial public offering and private placement	$ 28,883,589

Description of Organization and

Description of Organization and Business Operations	10 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	Fusion Acquisition Corp. (the “Company”) was incorporated in Delaware on March 6, 2020. The Company was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, however, the Company intends to concentrate its efforts identifying businesses in the financial services industry, with particular emphasis on businesses in the wealth, financial advice, investment, and asset management sectors or those that are providing or changing technology for traditional financial services. The Company has one subsidiary, ML Merger Sub, Inc., a wholly-owned subsidiary of the Company incorporated in Delaware on February 9, 2021 (“Merger Sub”). As of December 31, 2020, the Company had not commenced any operations. All activity for the period from March 6, 2020 (inception) through December 31, 2020 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, identifying a target company for a Business Combination, and activities in connection with the proposed acquisition of MoneyLion Inc. (“MoneyLion”) (see Note 11). The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on June 25, 2020. On June 30, 2020, the Company consummated the Initial Public Offering of 35,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which includes the partial exercise by the underwriters of their over-allotment option in the amount of 4,500,000 Units, at $10.00 per Unit, generating gross proceeds of $350,000,000, which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 8,100,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Fusion Sponsor LLC (the “Sponsor”), generating gross proceeds of $8,100,000, which is described in Note 5. The Private Placement Warrants had an estimated fair value of $9,166,689 as of the closing of the Initial Public Offering, resulting in a $1,066,689 non-cash loss to the Company equal to the excess of fair value over the cash received for the Private Placement Warrants. Transaction costs amounted to $19,834,039, consisting of $6,100,000 of underwriting fees, $13,150,000 of deferred underwriting fees and $584,039 of other offering costs. Following the closing of the Initial Public Offering on June 30, 2020, an amount of $350,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) located in the United States and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more operating businesses or assets that together have an aggregate fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting commissions) at the time of the Company’s signing a definitive agreement in connection with its initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires an interest in the target business or assets sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will only proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by applicable law or stock exchange rules and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange rules, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 6), and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all. Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company. The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Company will have until December 31, 2021 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern In connection with the Company’s assessment of going concern considerations in accordance with FASB’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that if the Company is unable to raise additional funds to alleviate liquidity needs as well as complete a Business Combination by December 31, 2021, then the Company will cease all operations except for the purpose of liquidating. The liquidity condition and date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December 31, 2021.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	10 Months Ended
	Dec. 31, 2020
Condensed Financial Information Disclosure [Abstract]
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS The Company previously accounted for its outstanding warrants as components of equity instead of as derivative liabilities. The warrant agreement governing the warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant. Upon review of the “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (SPACs)” promulgated by the SEC on April 12, 2021, the Company’s management further evaluated the warrants under Accounting Standards Codification (“ASC”) Subtopic 815-40, Contracts in Entity’s Own Equity. ASC Section 815-40-15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants, and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer’s common stock. Under ASC Section 815-40-15, a warrant is not indexed to the issuer’s common stock if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant. An instrument would be considered indexed to an entity’s own stock if its settlement amount were equal the difference between the fair value of a fixed number of the entity’s equity shares and a fixed monetary amount or an instrument that includes variables that would be inputs to the fair value of a fixed-for-fixed forward or option on equity shares. Based on management’s evaluation, the Company’s audit committee, in consultation with management, concluded that the Company’s warrants are not indexed to the Company’s common shares in the manner contemplated by ASC Section 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. As a result of the above, the Company is reclassifying the warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results for the current period. The Company’s accounting for the warrants as components of equity instead of as derivative liabilities did have an effect on the Company’s previously reported operating expenses and cash flows. Since the warrants were issued on June 30, 2020, it would have an effect on the profit and loss because of the allocation of the IPO expenses to the warrants on the balance sheet as of March 31, 2020 (unaudited) as well as the respective statements of operations for the period from March 6, 2020 (inception) through March 31, 2020 (unaudited), three months ended June 30, 2020 (unaudited) and period from March 6, 2020 (inception) through June 30, 2020 (unaudited). As Previously Reported Adjustment As Restated Balance Sheet as of June 30, 2020 Warrant liability $ - 28,883,589 $ 28,883,589 Total Liabilities 13,150,000 28,883,589 42,033,589 Class A common stock, subject to redemption 333,288,890 (28,883,589 ) 304,405,301 Class A Common Stock 167 289 456 Additional paid-in capital 5,001,029 1,617, 752 6,618,781 Accumulated deficit (2,062 ) (1,618,041 ) (1,620,103 ) Total Stockholders’ Equity (deficit) (5,000,010 ) - (5,000,010 ) Balance Sheet as of September 30, 2020 Warrant Liability $ - $ 28,046,317 $ 28,046,317 Total Liabilities 13,242,334 28,046,317 41,288,651 Class A Common Stock, subject to possible redemption 333,100,530 (28,046,317 ) 305,054,213 Class A common stock 169 289 458 Additional paid-in capital 5,189,387 780,480 5,969,867 Accumulated deficit (190,427 ) (780,769 ) (971,196 ) Total Stockholders’ Equity (deficit) (5,000,004 ) - (5,000,004 ) Balance Sheet as of December 31, 2020 (audited) Warrant Liability $ - $ 66,126,490 $ 66,126,490 Total Liabilities 13,401,040 66,126,490 79,527,530 Class A common stock 332,882,720 (66,126,490 ) 266,756,230 Shareholder’s equity Class A Common Stock 171 661 832 Additional paid-in capital 5,407,195 38,860,281 44,267,476 Accumulated deficit (408,237 ) (38,860,942 ) (39,269,179 ) Total Stockholders’ Equity (deficit) (5,000,004 ) - (5,000,004 ) As Previously Reported Adjustments As Restated Statement of Operations for the period from March 6, 2020 to June 30, 2020 (unaudited) Formation and operating costs $ 2,062 $ 551,352 $ 553,414 Change in the fair value of the warrants 1,066,689 1,066,689 (Loss) Gain before provision for income taxes (2,062) (1,618,041) (1,620,103) Provision for income taxes - - - Net (loss) gain (2,062 ) (1,618,041 ) (1,620,103 ) Basic and diluted net income per common share, Class A, - - - Basic and diluted net (loss) income per common share, Class B (0.00 ) (0.19 ) (0.19 ) Statement of Operations for the three months ended September 30, 2020 (unaudited) Formation and operating costs 284,765 - 284,765 Change in fair value of warrants $ - $ 837,272 $ 837,272 (Loss) Gain before provision for income taxes (176,031 ) 837,272 661,241 Provision for income taxes (12,334) - (12,334) Net (loss) gain (188,365 ) 837,272 (648,907) Basic and diluted net income per common share, Class A 0.00 0.02 0.02 Basic and diluted net (loss) income per common share, Class B (0.03 ) (0.04 ) (0.07 ) Statement of Operations for the Period From March 6, 2020 (inception) to September 30, 2020 (unaudited) Formation and operating costs $ 286,827 $ 551,352 $ 838,179 Loss from operations (286,827 ) (551,352 ) (838,179 ) Change in fair value of derivative warrant liability - (229,417 ) (229,417 ) (Loss) Gain before provision for income taxes (178,093 ) (780,769 ) (958,862 ) Provision for income taxes (12,334) - (12,334) Net (loss) gain (190,427 ) (780,769 ) (971,196 ) Basic and diluted net income per common share, Class A 0.00 0.00 0.00 Basic and diluted net (loss) income per common share, Class B (0.03 ) 0.06 (0.03 ) Statement of Operations for the Period From March 6, 2020 (inception) to December 31, 2020 (audited) Formation and operating costs $ 616,065 $ 551,352 $ 1,167,417 Loss from operations (616,065 ) (551,352 ) (1,167,417 ) Change in fair value of warrants - (38,309,590 ) (38,309,590 ) Loss before provision for income taxes (396,728 ) (38,860,942 ) (39,257,670 ) Provision for income taxes 11,509 - 11,509 Net (loss) gain (408,237 ) (38,860,942 ) (39,269,179 ) Basic and diluted net income per common share, Class A 0.00 - - Basic and diluted net (loss) income per common share, Class B (0.05 ) (4.4 4) (4.49 ) Statement of Cash Flows As Previously Reported Adjustments As Restated Period from March 6, 2020 (inception) to June 30, 2020 (unaudited) Cash flows from Operating Activities: Net loss $ (2,062 ) $ (1,618,041 ) $ (1,620,103 ) Adjustments to reconcile net loss to net cash used in operating activities: Expenses allocated to operations from offering costs related to derivative warrant liability - 1,618,041 1,618,041 Non-cash investing and financing activities: Initial classification of common stock subject to possible redemption 333,288,890 (28,883,589 ) 304,405,301 Adjustment of common stock par value 289 289 Period from March 6, 2020 (inception) to September 30, 2020 (unaudited) Cash flows from Operating Activities: Net (loss)/gain $ (190,427 ) $ (780,769 ) $ (971,196 ) Adjustments to reconcile net loss to net cash used in operating activities: Change in fair value of warrants $ - 229,417 229,417 Expenses allocated to operations from offering costs related to derivative warrant liability - 551,352 551,352 Non-cash investing and financing activities: Initial classification of common stock subject to possible redemption 333,288,890 (28,046,317 ) 305,242,573 Change in value of common stock subject to possible redemption (188,360 ) (460,552 ) (648,912 ) Adjustment of common stock par value 289 289 Period from March 6, 2020 (inception) to December 31, 2020 (audited) Cash flows from Operating Activities: Net loss $ (408,237 ) $ (38,860,942 ) $ (39,269,179 ) Adjustments to reconcile net loss to net cash used in operating activities: Change in fair value of warrants $ - 38,309,590 38,309,590 Expenses allocated to operations from offering costs related to derivative warrant liability - 1,618,041 1,618,041 Non-cash investing and financing activities: Initial classification of common stock subject to possible redemption 333,288,890 (66,126,490 ) 267,162,400 Change in value of common stock subject to possible redemption (406,170 ) 38,704,153 38,397,983 Condensed Statement of Changes in Stockholders’ Equity As Previously Reported Adjustments As Restated As of June 30, 2020 Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Balance — March 31, 2020 $ - $ 877 $ 24,123 $ (1,000 ) $ 24,000 $ - $ - $ - $ - $ - $ - $ 877 $ 24,123 $ (1,000 ) $ 24,000 Sale of 35,000,000 Units, net of underwriting discounts and offering expenses 3,500 - 330,162,461 - 330,165,961 - - 19,165,548 0 19,165,548 3,500 - 310,996,913 - 311,000,413 Sale of 8,100,000 Private Placement Warrants - - 8,100,000 - 8,100,000 - - 8,100,000 - (8,100,000 ) - - - - - Forfeiture of Founder Shares - (2 ) 2 - - - - - - - - (2 ) 2 - - Common stock subject to possible redemption (3,333 ) - (333,285,557 ) - (333,288,890 ) 289 - (28,883,300 ) - - (3,004 ) - (304,402,256 ) - (304,405,301 ) Net loss - - - (1,062 ) (1,062 ) - - - (1,618,041 ) (1,618,041 ) - - - (1,619,103 ) (1,619,103 ) Balance — June 30, 2020 167 875 5,001,029 (2,062 ) 5,000,009 289 - 1,617,752 (1,618,041 ) - 456 875 6,618,781 (1,620,103 ) 5,000,009 Condensed Statement of Changes in Stockholders’ Equity As Previously Reported Adjustments As Restated As of September 30, 2020 Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Balance — March 31, 2020 $ - $ 877 $ 24,123 $ (1,000 ) $ 24,000 $ - $ - $ - $ - $ - $ - $ 877 $ 24,123 $ (1,000 ) $ 24,000 Sale of 35,000,000 Units, net of underwriting discounts and offering expenses 3,500 - 330,162,461 - 330,165,961 - - 19,165,548 - 19,165,548 3,500 - 310,996,913 - 311,000,413 Sale of 8,100,000 Private Placement Warrants - - 8,100,000 - 8,100,000 - - (8,100,000 ) - (8,100,000 ) - - - - - Forfeiture of Founder Shares - (2 ) 2 - - - - - - - - (2 ) 2 - - Common stock subject to possible redemption (3,333 ) - (333,285,557 ) - (333,288,890 ) 289 28,883,300 - 28,883,589 28,883,589 (3,044 ) - (304,402,257 ) - (304,405,301 ) Net loss - - - (1,062 ) (1,062 ) - - - (1,618,041 ) (1,618,041 ) - - - (1,619,103 ) (1,619,103 ) Balance — June 30, 2020 167 875 5,001,029 (2,062 ) 5,000,009 289 - 1,617,752 (1,618,041 ) - 456 875 6,618,781 (1,620,103 ) 5,000,009 Sale of 35,000,000 Units, net of underwriting discounts and offering expenses 641,900 - 641,900 - - 641,900 - 641,900 Sale of 8,100,000 Private Placement Warrants 195,372 (56,503 ) 138,869 - - 195,372 (56,503 ) (138,869 ) Common stock subject to possible redemption - - 188,358 - 188,358 - - - 188,358 - 188,358 Net loss 2 - - (188,365 ) (188,363 ) (780,769) (780,769 ) 2 - - (969,134) (969,132) Balance — September 30, 2020 169 875 5,189,387 (190,427 ) 5,000,004 289 - 2,455,024 (2,455,313 ) - 458 875 7,644,411 (2,645,740 ) 5,000,005 Condensed Statement of Changes in Stockholders’ Equity As Previously Reported Adjustments As Restated As of December 31, 2020 Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Balance — March 6, 2020 (inception date) $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - Issuance of Class B common stock to Sponsor 877 24,123 25,000 - - 877 24,123 - 25,000 Sale of 35,000,000 Units, net of underwriting discounts and offering expenses 3,500 - 330,162,461 - 330,165,961 (25,083,100 ) (25,083,100 ) 3,500 - 330,162,461 (25,083,100 ) 305,082,861 Sale of 8,100,000 Private Placement Warrants - 8,100,000 - 8,100,000 (8,100,000 ) (13,226,490 ) (21,326,490 ) - - - (13,226,490 ) (13,226,490 ) Forfeiture of Founder Shares - (2 ) 2 - - - - (2 ) 2 - - Class A common stock subject to possible redemption (3,329 ) - (332,879,391 ) - (332,882,720 ) 661 46,960,942 46,960,942 (2,668 ) - (285,918,449 ) - (285,921,778 ) Net loss - - - (408,237 ) (408,237 ) (551,352 ) (551,352 ) - - - (959,589 ) (959,589 ) Balance — December 31, 2020 171 875 5,407,195 (408,237 ) 5,000,004 661 - 38,860,281 (38,860,942 ) - 832 875 44,267,476 (39,269,179 ) 5,000,004

Summary of Significant Accounti

Summary of Significant Accounting Policies	10 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, the 33,286,067 shares of Class A common stock subject to possible redemption at December 31, 2020 is presented as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. Warrant Liability The Company accounts for its outstanding Public Warrants and Private Placement Warrants (collectively, the “Warrants”) in accordance with the guidance contained in Accounting Standards Codification 815-40, “Derivatives and Hedging — Contracts on an Entity’s Own Equity” (“ASC 815-40”) and determined that the Warrants do not meet the criteria for equity treatment thereunder. As such, each Warrant must be recorded as a liability and is subject to re-measurement at each balance sheet date and any change in fair value is recognized in the Company’s statements of operations. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The fair value of the warrants was estimated using a Monte Carlo simulation approach. Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Net Loss per Common Share Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding shares of common stock subject to forfeiture by the Sponsor, if any. The Company has not considered the effect of warrants sold in the Initial Public Offering and private placement to purchase 25,600,000 shares of common stock in the calculation of diluted income (loss) per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method. As a result, diluted loss per share is the same as basic loss per share for the period presented. The Company’s statement of operations includes a presentation of income (loss) per share for common shares subject to possible redemption in a manner similar to the two-class method of income (loss) per share. Net loss per common share, basic and diluted, for Class A redeemable common stock is calculated by dividing the interest income earned on the Trust Account net of applicable franchise and income taxes, by the weighted average number of shares of Class A redeemable common stock outstanding since original issuance. Net loss per share, basic and diluted, for Class B non-redeemable common stock is calculated by dividing the net loss, adjusted for net income attributable to Class A redeemable common stock, by the weighted average number of shares of Class B non-redeemable common stock outstanding for the period. Class B non-redeemable common stock includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account. The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): For the Period From March 6, 2020 (inception) Through December 31, 2020 As Previously Report Adjustments As Restated Redeemable Class A Common Stock Numerator: Earnings allocable to Redeemable Class A Common Stock Interest Income 219,337 - 219,337 Income and Franchise Tax (176,040 ) (176,040 ) Net Earnings 43,297 - 43,297 Denominator: Weighted Average Redeemable Class A Common Stock Redeemable Class A Common Stock, Basic and Diluted 35,000,000 - 35,000,000 Earnings/Basic and Diluted Redeemable Class A Common Stock 0.00 - 0.00 Non-Redeemable Class B Common Stock Numerator: Net Loss minus Redeemable Net Earnings Net Loss (408,237 ) (38,860,942 ) (39,269,179 ) Redeemable Net Earnings (43,297 ) - (43,297 ) Non-Redeemable Net Loss (451,534 ) (38,860,942 ) (39,312,476 ) Denominator: Weighted Average Non-Redeemable Class B Common Stock Non-Redeemable Class B Common Stock, Basic and Diluted 8,750,000 - 8,750,000 Loss/Basic and Diluted Non-Redeemable Class B Common Stock (0.05 ) (4.44 ) (4.49 ) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	10 Months Ended
	Dec. 31, 2020
Initial Public Disclosure Offering [Abstract]
INITIAL PUBLIC OFFERING	NOTE 4. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 35,000,000 Units at a price of $10.00 per Unit, which includes the partial exercise by the underwriters of their over-allotment option in the amount of 4,500,000 Units. Each Unit consists of one share of Class A common stock and one-half of one warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8).

Private Placement

Private Placement	10 Months Ended
	Dec. 31, 2020
Private Placement Disclosure [Abstract]
PRIVATE PLACEMENT	NOTE 5. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 8,100,000 Private Placement Warrants, at a price of $1.00 per warrant, for an aggregate purchase price of $8,100,000. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at an exercise price of $11.50 per share, subject to adjustment (see Note 8). A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless.

Related Party Transactions

Related Party Transactions	10 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares In March 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration of 5,750,000 shares of the Company’s Class B common stock (the “Founder Shares”). On May 28, 2020, the Company effected a 1:1.25 stock split with respect to the Class B common stock, on June 24, 2020, the Company effected a 1:1.20 stock split with respect to the Class B common stock and on June 25, 2020, the Company effected a 1:1.01666 stock split with respect to the Class B common stock, resulting in the Sponsor holding an aggregate of 8,768,750 Founder Shares. All share and per-share amounts have been retroactively restated to reflect the stock splits. The Founder Shares included an aggregate of up to 1,143,750 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder Shares would collectively represent approximately 20% of the Company’s issued and outstanding shares after the Initial Public Offering. In connection with the underwriters’ partial exercise of the over-allotment option and the forfeiture of the remaining over-allotment option, 18,750 Founder Shares were forfeited and 1,125,000 Founder Shares are no longer subject to forfeiture. As a result, there are 8,750,000 Founder Shares outstanding as of December 31, 2020. The Sponsor previously agreed pursuant to a letter agreement, dated as of June 25, 2020, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier of (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of Class A common stock for cash, securities or other property. Subsequently, in connection with the execution of the Merger Agreement, the Sponsor entered into a support agreement (the “Sponsor Support Agreement”) with the Company, MoneyLion and the Company’s directors and officers (the “Insiders”), pursuant to which the Sponsor agreed, among other things, to vote all shares of Subject Securities (as defined in the Sponsor Support Agreement), and take certain other actions in support of the Business Combination. In addition, the Company, the Sponsor and the Insiders agreed to amend that certain letter agreement, dated as of June 25, 2020, so that the Lock-Up Period (as defined in the Sponsor Support Agreement) applicable to the Subject Securities (other than any Private Placement Warrants (as defined in the Merger Agreement)) held by the Sponsor will end on the earlier of (a) 180 days after the effective date of the Merger Agreement (the “Effective Date”) and (b) the date on which the closing price of the shares of Class A common stock of New MoneyLion is equal to or greater than $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period; provided that, for purposes of this clause (b), the measurement period for determining the closing price of the share of Class A common stock of New MoneyLion shall commence no earlier than 60 days following the Effective Date. Administrative Support Agreement The Company entered into an agreement, commencing on June 25, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay the Sponsor $10,000 per month for office space, secretarial, and administrative services. For period from March 6, 2020 (inception) through December 31, 2020, the Company incurred $60,000 in fees for these services, which are included in accrued expenses in the accompanying balance sheet. Management Fee On July 7, 2020, the Company’s board of directors approved payments of $15,000 per month to the Company’s Chief Financial Officer for services rendered to the Company commencing on June 25, 2020 and continuing through the earlier of consummation of a Business Combination or the Company’s liquidation. For the period from March 6, 2020 (inception) through December 31, 2020, the Company incurred and paid $90,000 in fees for these services. Promissory Note — Related Party On March 10, 2020, the Sponsor issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $200,000. The Promissory Note was non-interest bearing and payable on the earlier of December 31, 2020 or the consummation of the Initial Public Offering. The outstanding balance under the Promissory Note of $186,165 was repaid on June 30, 2020. Related Party Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2020, no Working Capital Loans were outstanding.

Commitments

Commitments	10 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS	NOTE 7. COMMITMENTS Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Registration Rights Pursuant to a registration rights agreement entered into on June 25, 2020, the holders of the Founder Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Class A common stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to 4,575,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. In connection with the closing of the Initial Public Offering on June 30, 2020, the underwriters partially exercised their over-allotment option to purchase an additional 4,500,000 Units at $10.00 per Unit and forfeited the option to exercise the remaining 75,000 Units. The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $6,100,000 in the aggregate. In addition, the underwriters are entitled to a deferred fee of (i) 3.5% of the gross proceeds of the initial 30,500,000 Units sold in the Initial Public Offering, or $10,675,000, and (ii) 5.5% of the gross proceeds from the Units sold pursuant to the over-allotment option, or $2,475,000. Up to 10% of the deferred commission relating to the base offering may be paid at the sole discretion of the Company to third parties not participating in the Initial Public Offering (but who are members of FINRA) that assist the Company in consummating the Business Combination. The deferred fee will be forfeited by the underwriters solely in the event that the Company fails to complete a Business Combination, subject to the terms of the underwriting agreement.

Stockholders' Equity

Stockholders' Equity	10 Months Ended
	Dec. 31, 2020
Stockholders' Equity Note [Abstract]
STOCKHOLDERS' EQUITY	NOTE 8. STOCKHOLDERS’ EQUITY Preferred Stock Class A Common Stock Class B Common Stock Holders of Class A common stock and Class B common stock will vote together as a single class on all matters submitted to a vote of stockholders except as required by law. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with a Business Combination, the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in a Business Combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans, provided that such conversion of Founder Shares will never occur on a less than one-for-one basis. Warrants — The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue any shares of Class A common stock upon exercise of a warrant unless the share of Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement registering the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its best efforts to qualify the shares under applicable blue sky laws to the extent an exemption is not available. Redemption of warrants for cash ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption to each warrant holder; and ● if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like and for certain issuances of Class A common stock and equity-linked securities for capital raising purposes in connection with the closing of our initial business combination as described elsewhere in this prospectus) for any 20 trading days within a 30-trading day period ending three business days before we send to the notice of redemption to the warrant holders. If and when the warrants become redeemable by the Company, it may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for redemption for cash, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuance of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), (the “Newly Issued Price”) (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the shares of Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, and will be entitled to certain registration rights (see Note 7). Additionally, the Private Placement Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by such holders on the same basis as the Public Warrants.

Income Tax

Income Tax	10 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
INCOME TAX	NOTE 9. INCOME TAX The Company’s net deferred tax asset is as follows: December 31, 2020 Deferred tax asset Organizational costs/Startup expenses $ 94,822 Total deferred tax asset 94,822 Valuation allowance (94,822 ) Deferred tax asset, net of allowance $ — The income tax provision consists of the following: December 31, 2020 Federal Current $ 11,509 Deferred (94,822 ) State Current $ — Deferred — Change in valuation allowance 94,822 Income tax provision $ 11,509 As of December 31, 2020, the Company did not have any U.S. federal and state net operating loss carryovers available to offset future taxable income. In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the period from March 6, 2020 (inception) through December 31, 2020, the change in the valuation allowance was $94,822. A reconciliation of the federal income tax rate to the Company’s effective tax rate is as follows: December 31, 2020 Statutory federal income tax rate 21.0 % State taxes, net of federal tax benefit 0.0 % Change in valuation allowance (24.0 )% Income tax provision (3.0 )% The Company files income tax returns in the U.S. federal jurisdiction in various state and local jurisdictions and is subject to examination by the various taxing authorities.

Fair Value Measurements

Fair Value Measurements	10 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 10. FAIR VALUE MEASUREMENTS The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheet and adjusted for the amortization or accretion of premiums or discounts. At December 31, 2020, assets held in the Trust Account were comprised of $642 in cash and $350,218,694 in U.S. Treasury securities. During the year ended December 31, 2020, the Company did not withdraw any interest income from the Trust Account. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. The gross holding gains and fair value of held-to-maturity securities at December 31, 2020 are as follows: Fair Value at Level 2020 Assets: Marketable securities held in Trust Account 1 $ 350,218,694 Liabilities: Warrant Liability – Public Warrants 1 $ 44,800,000 Warrant Liability – Private Placement Warrants 3 $ 21,326,510 Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. There were no transfers between levels for the year ended December 31, 2020 other than the transfer of the public warrants from Level 3 to Level 1. The warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on our balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the statement of operations. Initial Measurement – Public Warrants The Company established the initial fair value for the public warrants on June 30, 2020, the date of the Company’s Initial Public Offering, using a Monte Carlo simulation implementing the Black-Scholes Option Pricing Model that was modified to capture the redemption features of the public warrants. The underlying assumptions in the Black-Scholes option pricing model include the underlying share price, risk-free interest rate, estimated volatility and the expected term. The primary unobservable inputs utilized in determining the fair value of the public warrants are the expected volatility of the Company’s common stock and our common stock price. The expected volatility of our common stock was determined based on implied volatilities of public warrants issued by selected guideline companies and was estimated to be 10% before the expected business combination and 20% after the expected business combination. Our common stock price was determined based on an iterative procedure that matched the estimated value of the common stock and fractional warrant price to equate to the observed price of our outstanding units. The risk-free interest rate is based on the U.S. Treasury yield curve in effect on the date of valuation equal to the remaining expected life of the public warrants. The dividend yield percentage is zero because the Company does not currently pay dividends, nor does it intend to do so during the expected term of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Inputs are re-evaluated each quarterly reporting period to estimate the fair market value of the private placement warrants as of the reporting period. On June 30, 2020, the public warrants’ fair value was $1.13 per warrant for an aggregate value of $19.7 million. F- 23 Subsequent Measurement – Public Warrants The public warrants are measured at fair value on a recurring basis. The public warrants were valued using the instrument’s publicly listed trading price as of September 30, 2020 and December 31, 2020, which is considered to be a Level 1 measurement due to the use of an observable market quote in an active market. As of September 30, 2020, the aggregate value of the public warrants was $19.1 million and as of December 31, 2020, the aggregate value of the public warrants was $44.8 million. Initial Measurement – Private Placement Warrants The private placement warrants were valued using a Black-Scholes option pricing model, which is considered to be a Level 3 fair value measurement. The underlying assumptions in the Black-Scholes option pricing model include the underlying share price, risk-free interest rate, estimated volatility and the expected term. The primary unobservable inputs utilized in determining fair value of the private placement warrants are the expected volatility of our common stock and our common stock price. The expected volatility of our common stock was determined based on implied volatilities of public warrants issued by selected guideline companies and was estimated to be 10% before the expected business combination and 20% after the expected business combination. Our stock price was determined based on an iterative procedure that matched the estimated value of the common stock and fractional warrant price to equate to the observed price of our outstanding units. The risk-free interest rate is based on the U.S. Treasury yield curve in effect on the date of valuation equal to the remaining expected life of the public warrants. The dividend yield percentage is zero because the Company does not currently pay dividends, nor does it intend to do so during the expected term of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Inputs are re-evaluated each quarterly reporting period to estimate the fair market value of the private placement warrants as of the reporting period. On June 30, 2020, the private placement warrants’ fair value was $1.13 per warrant for an aggregate value of $9.2 million. Subsequent Measurement – Private Placement Warrants On September 30, 2020, the private placement warrants were valued using a Black-Scholes option pricing model, which is considered to be a Level 3 fair value measurement. The primary unobservable inputs utilized in determining fair value of the private placement warrants is the expected volatility of our common stock. The expected volatility of our common stock was determined based on implied volatility of the public warrants and was estimated to be 10% before the expected business combination and 18.5% after the expected business combination. Updating the remaining inputs to the Black-Scholes option pricing model as of September 30, 2020 resulted in the private placement warrants’ fair value of $1.11 per warrant for an aggregate value of $9.0 million. On December 31, 2020, the private placement warrants were valued using a Black-Scholes option pricing model, which is considered to be a Level 3 fair value measurement. The primary unobservable inputs utilized in determining fair value of the private placement warrants is the expected volatility of our common stock. The expected volatility of our common stock was determined based on implied volatility of the public warrants and was estimated to be 10% before the expected business combination and 26.5% after the expected business combination. Updating the remaining inputs to the Black-Scholes option pricing model as of December 31, 2020 resulted in the private placement warrants’ fair value of $2.63 per warrant for an aggregate value of $21.3 million.

Subsequent Events

Subsequent Events	10 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 11. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. On February 11, 2021, the Company entered into an agreement and plan of merger (the “Merger Agreement”), by and among the Company, Merger Sub and MoneyLion, which provides for Merger Sub to merge with and into MoneyLion with MoneyLion surviving the merger as a wholly owned subsidiary of the Company (the “Business Combination”). In addition, in connection with the consummation of the Business Combination, the Company will be renamed as determined by MoneyLion and is referred to herein as “New MoneyLion” as of the time following such change of name. Under the Merger Agreement, the Company has agreed to acquire all of the outstanding shares of common stock of MoneyLion for $2,200,000,000 in aggregate consideration. MoneyLion stockholders will receive shares of Class A common stock of New MoneyLion (valued at $10.00 per share), and, if elected by MoneyLion, cash consideration up to the lower of (A) the amount (which may be zero) by which the Parent Closing Cash (as defined in the Merger Agreement) exceeds $260,000,000 and (B) $100,000,000, together with a contingent right to receive a pro rata portion of up to 17,500,000 shares of Class A common stock of New MoneyLion (the “Earn Out Shares”). The Merger Agreement contains customary representations, warranties and covenants by the parties thereto and the closing is subject to certain conditions as further described in the Merger Agreement.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	10 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, the 33,286,067 shares of Class A common stock subject to possible redemption at December 31, 2020 is presented as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.
Warrant Liability	Warrant Liability The Company accounts for its outstanding Public Warrants and Private Placement Warrants (collectively, the “Warrants”) in accordance with the guidance contained in Accounting Standards Codification 815-40, “Derivatives and Hedging — Contracts on an Entity’s Own Equity” (“ASC 815-40”) and determined that the Warrants do not meet the criteria for equity treatment thereunder. As such, each Warrant must be recorded as a liability and is subject to re-measurement at each balance sheet date and any change in fair value is recognized in the Company’s statements of operations. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The fair value of the warrants was estimated using a Monte Carlo simulation approach.
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
Net Loss per Common Share	Net Loss per Common Share Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding shares of common stock subject to forfeiture by the Sponsor, if any. The Company has not considered the effect of warrants sold in the Initial Public Offering and private placement to purchase 25,600,000 shares of common stock in the calculation of diluted income (loss) per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method. As a result, diluted loss per share is the same as basic loss per share for the period presented. The Company’s statement of operations includes a presentation of income (loss) per share for common shares subject to possible redemption in a manner similar to the two-class method of income (loss) per share. Net loss per common share, basic and diluted, for Class A redeemable common stock is calculated by dividing the interest income earned on the Trust Account net of applicable franchise and income taxes, by the weighted average number of shares of Class A redeemable common stock outstanding since original issuance. Net loss per share, basic and diluted, for Class B non-redeemable common stock is calculated by dividing the net loss, adjusted for net income attributable to Class A redeemable common stock, by the weighted average number of shares of Class B non-redeemable common stock outstanding for the period. Class B non-redeemable common stock includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account. The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): For the Period From March 6, 2020 (inception) Through December 31, 2020 As Previously Report Adjustments As Restated Redeemable Class A Common Stock Numerator: Earnings allocable to Redeemable Class A Common Stock Interest Income 219,337 - 219,337 Income and Franchise Tax (176,040 ) (176,040 ) Net Earnings 43,297 - 43,297 Denominator: Weighted Average Redeemable Class A Common Stock Redeemable Class A Common Stock, Basic and Diluted 35,000,000 - 35,000,000 Earnings/Basic and Diluted Redeemable Class A Common Stock 0.00 - 0.00 Non-Redeemable Class B Common Stock Numerator: Net Loss minus Redeemable Net Earnings Net Loss (408,237 ) (38,860,942 ) (39,269,179 ) Redeemable Net Earnings (43,297 ) - (43,297 ) Non-Redeemable Net Loss (451,534 ) (38,860,942 ) (39,312,476 ) Denominator: Weighted Average Non-Redeemable Class B Common Stock Non-Redeemable Class B Common Stock, Basic and Diluted 8,750,000 - 8,750,000 Loss/Basic and Diluted Non-Redeemable Class B Common Stock (0.05 ) (4.44 ) (4.49 )
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	10 Months Ended
	Dec. 31, 2020
Condensed Financial Information Disclosure [Abstract]
Schedule of consolidated Balance Sheet	As Previously Reported Adjustment As Restated Balance Sheet as of June 30, 2020 Warrant liability $ - 28,883,589 $ 28,883,589 Total Liabilities 13,150,000 28,883,589 42,033,589 Class A common stock, subject to redemption 333,288,890 (28,883,589 ) 304,405,301 Class A Common Stock 167 289 456 Additional paid-in capital 5,001,029 1,617, 752 6,618,781 Accumulated deficit (2,062 ) (1,618,041 ) (1,620,103 ) Total Stockholders’ Equity (deficit) (5,000,010 ) - (5,000,010 ) Balance Sheet as of September 30, 2020 Warrant Liability $ - $ 28,046,317 $ 28,046,317 Total Liabilities 13,242,334 28,046,317 41,288,651 Class A Common Stock, subject to possible redemption 333,100,530 (28,046,317 ) 305,054,213 Class A common stock 169 289 458 Additional paid-in capital 5,189,387 780,480 5,969,867 Accumulated deficit (190,427 ) (780,769 ) (971,196 ) Total Stockholders’ Equity (deficit) (5,000,004 ) - (5,000,004 ) Balance Sheet as of December 31, 2020 (audited) Warrant Liability $ - $ 66,126,490 $ 66,126,490 Total Liabilities 13,401,040 66,126,490 79,527,530 Class A common stock 332,882,720 (66,126,490 ) 266,756,230 Shareholder’s equity Class A Common Stock 171 661 832 Additional paid-in capital 5,407,195 38,860,281 44,267,476 Accumulated deficit (408,237 ) (38,860,942 ) (39,269,179 ) Total Stockholders’ Equity (deficit) (5,000,004 ) - (5,000,004 )
Schedule of consolidated statement of operations	As Previously Reported Adjustments As Restated Statement of Operations for the period from March 6, 2020 to June 30, 2020 (unaudited) Formation and operating costs $ 2,062 $ 551,352 $ 553,414 Change in the fair value of the warrants 1,066,689 1,066,689 (Loss) Gain before provision for income taxes (2,062) (1,618,041) (1,620,103) Provision for income taxes - - - Net (loss) gain (2,062 ) (1,618,041 ) (1,620,103 ) Basic and diluted net income per common share, Class A, - - - Basic and diluted net (loss) income per common share, Class B (0.00 ) (0.19 ) (0.19 ) Statement of Operations for the three months ended September 30, 2020 (unaudited) Formation and operating costs 284,765 - 284,765 Change in fair value of warrants $ - $ 837,272 $ 837,272 (Loss) Gain before provision for income taxes (176,031 ) 837,272 661,241 Provision for income taxes (12,334) - (12,334) Net (loss) gain (188,365 ) 837,272 (648,907) Basic and diluted net income per common share, Class A 0.00 0.02 0.02 Basic and diluted net (loss) income per common share, Class B (0.03 ) (0.04 ) (0.07 ) Statement of Operations for the Period From March 6, 2020 (inception) to September 30, 2020 (unaudited) Formation and operating costs $ 286,827 $ 551,352 $ 838,179 Loss from operations (286,827 ) (551,352 ) (838,179 ) Change in fair value of derivative warrant liability - (229,417 ) (229,417 ) (Loss) Gain before provision for income taxes (178,093 ) (780,769 ) (958,862 ) Provision for income taxes (12,334) - (12,334) Net (loss) gain (190,427 ) (780,769 ) (971,196 ) Basic and diluted net income per common share, Class A 0.00 0.00 0.00 Basic and diluted net (loss) income per common share, Class B (0.03 ) 0.06 (0.03 ) Statement of Operations for the Period From March 6, 2020 (inception) to December 31, 2020 (audited) Formation and operating costs $ 616,065 $ 551,352 $ 1,167,417 Loss from operations (616,065 ) (551,352 ) (1,167,417 ) Change in fair value of warrants - (38,309,590 ) (38,309,590 ) Loss before provision for income taxes (396,728 ) (38,860,942 ) (39,257,670 ) Provision for income taxes 11,509 - 11,509 Net (loss) gain (408,237 ) (38,860,942 ) (39,269,179 ) Basic and diluted net income per common share, Class A 0.00 - - Basic and diluted net (loss) income per common share, Class B (0.05 ) (4.4 4) (4.49 )
Schedule of statement of cash flows	Statement of Cash Flows As Previously Reported Adjustments As Restated Period from March 6, 2020 (inception) to June 30, 2020 (unaudited) Cash flows from Operating Activities: Net loss $ (2,062 ) $ (1,618,041 ) $ (1,620,103 ) Adjustments to reconcile net loss to net cash used in operating activities: Expenses allocated to operations from offering costs related to derivative warrant liability - 1,618,041 1,618,041 Non-cash investing and financing activities: Initial classification of common stock subject to possible redemption 333,288,890 (28,883,589 ) 304,405,301 Adjustment of common stock par value 289 289 Period from March 6, 2020 (inception) to September 30, 2020 (unaudited) Cash flows from Operating Activities: Net (loss)/gain $ (190,427 ) $ (780,769 ) $ (971,196 ) Adjustments to reconcile net loss to net cash used in operating activities: Change in fair value of warrants $ - 229,417 229,417 Expenses allocated to operations from offering costs related to derivative warrant liability - 551,352 551,352 Non-cash investing and financing activities: Initial classification of common stock subject to possible redemption 333,288,890 (28,046,317 ) 305,242,573 Change in value of common stock subject to possible redemption (188,360 ) (460,552 ) (648,912 ) Adjustment of common stock par value 289 289 Period from March 6, 2020 (inception) to December 31, 2020 (audited) Cash flows from Operating Activities: Net loss $ (408,237 ) $ (38,860,942 ) $ (39,269,179 ) Adjustments to reconcile net loss to net cash used in operating activities: Change in fair value of warrants $ - 38,309,590 38,309,590 Expenses allocated to operations from offering costs related to derivative warrant liability - 1,618,041 1,618,041 Non-cash investing and financing activities: Initial classification of common stock subject to possible redemption 333,288,890 (66,126,490 ) 267,162,400 Change in value of common stock subject to possible redemption (406,170 ) 38,704,153 38,397,983
Schedule of condensed statement of changes in stockholders' equity	Condensed Statement of Changes in Stockholders’ Equity As Previously Reported Adjustments As Restated As of June 30, 2020 Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Balance — March 31, 2020 $ - $ 877 $ 24,123 $ (1,000 ) $ 24,000 $ - $ - $ - $ - $ - $ - $ 877 $ 24,123 $ (1,000 ) $ 24,000 Sale of 35,000,000 Units, net of underwriting discounts and offering expenses 3,500 - 330,162,461 - 330,165,961 - - 19,165,548 0 19,165,548 3,500 - 310,996,913 - 311,000,413 Sale of 8,100,000 Private Placement Warrants - - 8,100,000 - 8,100,000 - - 8,100,000 - (8,100,000 ) - - - - - Forfeiture of Founder Shares - (2 ) 2 - - - - - - - - (2 ) 2 - - Common stock subject to possible redemption (3,333 ) - (333,285,557 ) - (333,288,890 ) 289 - (28,883,300 ) - - (3,004 ) - (304,402,256 ) - (304,405,301 ) Net loss - - - (1,062 ) (1,062 ) - - - (1,618,041 ) (1,618,041 ) - - - (1,619,103 ) (1,619,103 ) Balance — June 30, 2020 167 875 5,001,029 (2,062 ) 5,000,009 289 - 1,617,752 (1,618,041 ) - 456 875 6,618,781 (1,620,103 ) 5,000,009 Condensed Statement of Changes in Stockholders’ Equity As Previously Reported Adjustments As Restated As of September 30, 2020 Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Balance — March 31, 2020 $ - $ 877 $ 24,123 $ (1,000 ) $ 24,000 $ - $ - $ - $ - $ - $ - $ 877 $ 24,123 $ (1,000 ) $ 24,000 Sale of 35,000,000 Units, net of underwriting discounts and offering expenses 3,500 - 330,162,461 - 330,165,961 - - 19,165,548 - 19,165,548 3,500 - 310,996,913 - 311,000,413 Sale of 8,100,000 Private Placement Warrants - - 8,100,000 - 8,100,000 - - (8,100,000 ) - (8,100,000 ) - - - - - Forfeiture of Founder Shares - (2 ) 2 - - - - - - - - (2 ) 2 - - Common stock subject to possible redemption (3,333 ) - (333,285,557 ) - (333,288,890 ) 289 28,883,300 - 28,883,589 28,883,589 (3,044 ) - (304,402,257 ) - (304,405,301 ) Net loss - - - (1,062 ) (1,062 ) - - - (1,618,041 ) (1,618,041 ) - - - (1,619,103 ) (1,619,103 ) Balance — June 30, 2020 167 875 5,001,029 (2,062 ) 5,000,009 289 - 1,617,752 (1,618,041 ) - 456 875 6,618,781 (1,620,103 ) 5,000,009 Sale of 35,000,000 Units, net of underwriting discounts and offering expenses 641,900 - 641,900 - - 641,900 - 641,900 Sale of 8,100,000 Private Placement Warrants 195,372 (56,503 ) 138,869 - - 195,372 (56,503 ) (138,869 ) Common stock subject to possible redemption - - 188,358 - 188,358 - - - 188,358 - 188,358 Net loss 2 - - (188,365 ) (188,363 ) (780,769) (780,769 ) 2 - - (969,134) (969,132) Balance — September 30, 2020 169 875 5,189,387 (190,427 ) 5,000,004 289 - 2,455,024 (2,455,313 ) - 458 875 7,644,411 (2,645,740 ) 5,000,005 Condensed Statement of Changes in Stockholders’ Equity As Previously Reported Adjustments As Restated As of December 31, 2020 Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Class A Common Stock Class B Common Stock Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Equity Balance — March 6, 2020 (inception date) $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - Issuance of Class B common stock to Sponsor 877 24,123 25,000 - - 877 24,123 - 25,000 Sale of 35,000,000 Units, net of underwriting discounts and offering expenses 3,500 - 330,162,461 - 330,165,961 (25,083,100 ) (25,083,100 ) 3,500 - 330,162,461 (25,083,100 ) 305,082,861 Sale of 8,100,000 Private Placement Warrants - 8,100,000 - 8,100,000 (8,100,000 ) (13,226,490 ) (21,326,490 ) - - - (13,226,490 ) (13,226,490 ) Forfeiture of Founder Shares - (2 ) 2 - - - - (2 ) 2 - - Class A common stock subject to possible redemption (3,329 ) - (332,879,391 ) - (332,882,720 ) 661 46,960,942 46,960,942 (2,668 ) - (285,918,449 ) - (285,921,778 ) Net loss - - - (408,237 ) (408,237 ) (551,352 ) (551,352 ) - - - (959,589 ) (959,589 ) Balance — December 31, 2020 171 875 5,407,195 (408,237 ) 5,000,004 661 - 38,860,281 (38,860,942 ) - 832 875 44,267,476 (39,269,179 ) 5,000,004

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	10 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Schedule of calculation of basic and diluted net income (loss) per common share	For the Period From March 6, 2020 (inception) Through December 31, 2020 As Previously Report Adjustments As Restated Redeemable Class A Common Stock Numerator: Earnings allocable to Redeemable Class A Common Stock Interest Income 219,337 - 219,337 Income and Franchise Tax (176,040 ) (176,040 ) Net Earnings 43,297 - 43,297 Denominator: Weighted Average Redeemable Class A Common Stock Redeemable Class A Common Stock, Basic and Diluted 35,000,000 - 35,000,000 Earnings/Basic and Diluted Redeemable Class A Common Stock 0.00 - 0.00 Non-Redeemable Class B Common Stock Numerator: Net Loss minus Redeemable Net Earnings Net Loss (408,237 ) (38,860,942 ) (39,269,179 ) Redeemable Net Earnings (43,297 ) - (43,297 ) Non-Redeemable Net Loss (451,534 ) (38,860,942 ) (39,312,476 ) Denominator: Weighted Average Non-Redeemable Class B Common Stock Non-Redeemable Class B Common Stock, Basic and Diluted 8,750,000 - 8,750,000 Loss/Basic and Diluted Non-Redeemable Class B Common Stock (0.05 ) (4.44 ) (4.49 )

Income Tax (Tables)

Income Tax (Tables)	10 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Schedule of company’s net deferred tax assets	December 31, 2020 Deferred tax asset Organizational costs/Startup expenses $ 94,822 Total deferred tax asset 94,822 Valuation allowance (94,822 ) Deferred tax asset, net of allowance $ —
Schedule of income tax provision	December 31, 2020 Federal Current $ 11,509 Deferred (94,822 ) State Current $ — Deferred — Change in valuation allowance 94,822 Income tax provision $ 11,509
Schedule of reconciliation of federal income tax rate to the company’s effective tax rate	December 31, 2020 Statutory federal income tax rate 21.0 % State taxes, net of federal tax benefit 0.0 % Change in valuation allowance (24.0 )% Income tax provision (3.0 )%

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	10 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Schedule of assets that are measured at fair value on a recurring basis	Fair Value at Level 2020 Assets: Marketable securities held in Trust Account 1 $ 350,218,694 Liabilities: Warrant Liability – Public Warrants 1 $ 44,800,000 Warrant Liability – Private Placement Warrants 3 $ 21,326,510

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)	1 Months Ended	10 Months Ended
	Jun. 30, 2020	Dec. 31, 2020
Description of Organization and Business Operations (Details) [Line Items]
Transaction costs		$ 19,834,039
Underwriting fees		6,100,000
Deferred underwriting fees		13,150,000
Other offering costs		584,039
Net proceeds		$ 311,000,413
Aggregate fair market value, percentage		80.00%
Business combination voting securities, percentage		50.00%
Net tangible assets		$ 5,000,001
Aggregate public shares, percentage		20.00%
Redeem of its public shares, percentage		100.00%
Interest to pay dissolution expenses		$ 100,000
Initial public offering price per unit (in Dollars per share)		$ 10
Liquidation of the trust account per share (in Dollars per share)		10
IPO [Member]
Description of Organization and Business Operations (Details) [Line Items]
Sale of stock in shares (in Shares)	35,000,000
Price per share (in Dollars per share)	$ 10	$ 10
Net proceeds	$ 350,000,000
Over-Allotment Option [Member]
Description of Organization and Business Operations (Details) [Line Items]
Sale of stock in shares (in Shares)	4,500,000	4,500,000
Price per share (in Dollars per share)	$ 10	$ 10
Gross proceeds	$ 350,000,000
Private Placement [Member]
Description of Organization and Business Operations (Details) [Line Items]
Sale of stock in shares (in Shares)		8,100,000
Gross proceeds		$ 8,100,000
Offering price per share (in Dollars per share)		$ 1
Fair value of warrants		$ 9,166,689
Non-cash loss on issue of warrants		$ 1,066,689

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements (Details) - Schedule of consolidated balance sheet - USD ($)	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020
As Previously Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant liability
Total Liabilities	13,401,040	13,242,334	13,150,000
Accumulated deficit	(408,237)	(190,427)	(2,062)
Total Stockholders’ Equity (deficit)	(5,000,004)	(5,000,004)	(5,000,010)
Balance Sheet as of September 30, 2020
Additional paid-in capital	5,407,195	5,189,387
As Previously Reported [Member] | Class A Common Stock
Condensed Financial Statements, Captions [Line Items]
Class A Common Stock, subject to possible redemption		333,100,530	333,288,890
Class A Common Stock	332,882,720	169	167
Additional paid-in capital			5,001,029
Balance Sheet as of December 31, 2020 (audited)
Shareholder’s equity Class A Common Stock	171
Adjustment [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant liability	66,126,490	28,046,317	28,883,589
Total Liabilities	66,126,490	28,046,317	28,883,589
Accumulated deficit	(38,860,942)	(780,769)	(1,618,041)
Total Stockholders’ Equity (deficit)
Balance Sheet as of September 30, 2020
Additional paid-in capital	38,860,281	780,480
Adjustment [Member] | Class A Common Stock
Condensed Financial Statements, Captions [Line Items]
Class A Common Stock, subject to possible redemption		(28,046,317)	(28,883,589)
Class A Common Stock	(66,126,490)	289	289
Additional paid-in capital			1,617,752
Balance Sheet as of December 31, 2020 (audited)
Shareholder’s equity Class A Common Stock	661
As Restated [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant liability	66,126,490	28,046,317	28,883,589
Total Liabilities	79,527,530	41,288,651	42,033,589
Accumulated deficit	(39,269,179)	(971,196)	(1,620,103)
Total Stockholders’ Equity (deficit)	(5,000,004)	(5,000,004)	(5,000,010)
Balance Sheet as of September 30, 2020
Additional paid-in capital	44,267,476	5,969,867
As Restated [Member] | Class A Common Stock
Condensed Financial Statements, Captions [Line Items]
Class A Common Stock, subject to possible redemption		305,054,213	304,405,301
Class A Common Stock	266,756,230	$ 458	456
Additional paid-in capital			$ 6,618,781
Balance Sheet as of December 31, 2020 (audited)
Shareholder’s equity Class A Common Stock	$ 832

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements (Details) - Schedule of consolidated statement of operations - USD ($)	3 Months Ended	4 Months Ended	7 Months Ended	10 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
As Previously Reported [Member]
Condensed Statement of Income Captions [Line Items]
Formation and operating costs	$ 284,765	$ 2,062	$ 286,827	$ 616,065
Change in fair value of warrants
(Loss) Gain before provision for income taxes	(176,031)	(2,062)	(178,093)	(396,728)
Provision for income taxes	(12,334)		(12,334)	11,509
Net (loss) gain	$ (188,365)	$ (2,062)	$ (190,427)	(408,237)
Basic and diluted net income per common share, Class A, (in Dollars per share)			$ 0
Basic and diluted net (loss) income per common share, Class B (in Dollars per share)			$ (0.03)
Statement of Operations for the Period From March 6, 2020 (inception) to September 30, 2020 (unaudited)
Loss from operations			$ (286,827)	$ (616,065)
Change in fair value of derivative warrant liability
As Previously Reported [Member] | Class A Common Stock
Condensed Statement of Income Captions [Line Items]
Basic and diluted net income per common share, Class A, (in Dollars per share)	$ 0			$ 0
As Previously Reported [Member] | Class B Common Stock
Condensed Statement of Income Captions [Line Items]
Basic and diluted net (loss) income per common share, Class B (in Dollars per share)	$ (0.03)	$ 0		$ (0.05)
Adjustment [Member]
Condensed Statement of Income Captions [Line Items]
Formation and operating costs		$ 551,352	551,352	$ 551,352
Change in fair value of warrants	$ 837,272	1,066,689		(38,309,590)
(Loss) Gain before provision for income taxes	837,272	(1,618,041)	(780,769)	(38,860,942)
Provision for income taxes
Net (loss) gain	$ 837,272	$ (1,618,041)	$ (780,769)	(38,860,942)
Basic and diluted net income per common share, Class A, (in Dollars per share)			$ 0
Basic and diluted net (loss) income per common share, Class B (in Dollars per share)			$ 0.06
Statement of Operations for the Period From March 6, 2020 (inception) to September 30, 2020 (unaudited)
Loss from operations			$ (551,352)	$ (551,352)
Change in fair value of derivative warrant liability			(229,417)
Adjustment [Member] | Class A Common Stock
Condensed Statement of Income Captions [Line Items]
Basic and diluted net income per common share, Class A, (in Dollars per share)	$ 0.02
Adjustment [Member] | Class B Common Stock
Condensed Statement of Income Captions [Line Items]
Basic and diluted net (loss) income per common share, Class B (in Dollars per share)	$ (0.04)	$ (0.19)		$ 4.4
As Restated [Member]
Condensed Statement of Income Captions [Line Items]
Formation and operating costs	$ 284,765	$ 553,414	838,179	$ 1,167,417
Change in fair value of warrants	837,272	1,066,689		(38,309,590)
(Loss) Gain before provision for income taxes	661,241	(1,620,103)	(958,862)	(39,257,670)
Provision for income taxes	(12,334)		(12,334)	11,509
Net (loss) gain	$ (648,907)	$ (1,620,103)	$ (971,196)	(39,269,179)
Basic and diluted net income per common share, Class A, (in Dollars per share)			$ 0
Basic and diluted net (loss) income per common share, Class B (in Dollars per share)			$ (0.03)
Statement of Operations for the Period From March 6, 2020 (inception) to September 30, 2020 (unaudited)
Loss from operations			$ (838,179)	$ (1,167,417)
Change in fair value of derivative warrant liability			$ (229,417)
As Restated [Member] | Class A Common Stock
Condensed Statement of Income Captions [Line Items]
Basic and diluted net income per common share, Class A, (in Dollars per share)	$ 0.02
As Restated [Member] | Class B Common Stock
Condensed Statement of Income Captions [Line Items]
Basic and diluted net (loss) income per common share, Class B (in Dollars per share)	$ (0.07)	$ (0.19)		$ (4.49)

Restatement of Previously Iss_5

Restatement of Previously Issued Financial Statements (Details) - Schedule of statement of cash flows - USD ($)	4 Months Ended	7 Months Ended	10 Months Ended
	Jun. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
As Previously Reported [Member]
Cash flows from Operating Activities:
Net (loss)/gain	$ (2,062)	$ (190,427)	$ (408,237)
Change in fair value of warrants
Expenses allocated to operations from offering costs related to derivative warrant liability
Non-cash investing and financing activities:
Initial classification of common stock subject to possible redemption	333,288,890	333,288,890	333,288,890
Change in value of common stock subject to possible redemption		(188,360)	(406,170)
Adjustment of common stock par value
Adjustments [Member]
Cash flows from Operating Activities:
Net (loss)/gain	(1,618,041)	(780,769)	(38,860,942)
Change in fair value of warrants		229,417	38,309,590
Expenses allocated to operations from offering costs related to derivative warrant liability	1,618,041	551,352	1,618,041
Non-cash investing and financing activities:
Initial classification of common stock subject to possible redemption	(28,883,589)	(28,046,317)	(66,126,490)
Change in value of common stock subject to possible redemption		(460,552)	38,704,153
Adjustment of common stock par value	289	289
As Restated [Member]
Cash flows from Operating Activities:
Net (loss)/gain	(1,620,103)	(971,196)	(39,269,179)
Change in fair value of warrants		229,417	38,309,590
Expenses allocated to operations from offering costs related to derivative warrant liability	1,618,041	551,352	1,618,041
Non-cash investing and financing activities:
Initial classification of common stock subject to possible redemption	304,405,301	305,242,573	267,162,400
Change in value of common stock subject to possible redemption		(648,912)	$ 38,397,983
Adjustment of common stock par value	$ 289	$ 289

Restatement of Previously Iss_6

Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity - USD ($)	3 Months Ended		10 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2020
As Previously Reported [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity [Line Items]
Balance	$ 5,000,009	$ 24,000
Issuance of Class B common stock to Sponsor			25,000
Sale of 35,000,000 Units, net of underwriting discounts and offering expenses		330,165,961	330,165,961
Sale of 8,100,000 Private Placement Warrants		8,100,000	8,100,000
Forfeiture of Founder Shares
Class A common stock subject to possible redemption	188,358	(333,288,890)	(332,882,720)
Net loss	(188,363)	(1,062)	(408,237)
Balance	5,000,004	5,000,009	5,000,004
Adjustments [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity [Line Items]
Balance
Issuance of Class B common stock to Sponsor
Sale of 35,000,000 Units, net of underwriting discounts and offering expenses	641,900	19,165,548	(25,083,100)
Sale of 8,100,000 Private Placement Warrants	138,869	(8,100,000)	(21,326,490)
Forfeiture of Founder Shares
Class A common stock subject to possible redemption		28,883,589	46,960,942
Net loss	(780,769)	(1,618,041)	(551,352)
Balance
As Restated [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity [Line Items]
Balance	5,000,009	24,000
Issuance of Class B common stock to Sponsor			25,000
Sale of 35,000,000 Units, net of underwriting discounts and offering expenses	641,900	311,000,413	305,082,861
Sale of 8,100,000 Private Placement Warrants	(138,869)		(13,226,490)
Forfeiture of Founder Shares
Class A common stock subject to possible redemption	188,358	(304,405,301)	(285,921,778)
Net loss	(969,132)	(1,619,103)	(959,589)
Balance	5,000,005	5,000,009	5,000,004
Additional Paid-in Capital [Member] | As Previously Reported [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity [Line Items]
Balance	5,001,029	24,123
Issuance of Class B common stock to Sponsor			24,123
Sale of 35,000,000 Units, net of underwriting discounts and offering expenses		330,162,461	330,162,461
Sale of 8,100,000 Private Placement Warrants		8,100,000	8,100,000
Forfeiture of Founder Shares		2	2
Class A common stock subject to possible redemption	188,358	(333,285,557)	(332,879,391)
Net loss
Balance	5,189,387	5,001,029	5,407,195
Additional Paid-in Capital [Member] | Adjustments [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity [Line Items]
Balance	1,617,752
Sale of 35,000,000 Units, net of underwriting discounts and offering expenses	641,900	19,165,548
Sale of 8,100,000 Private Placement Warrants	195,372	8,100,000	(8,100,000)
Forfeiture of Founder Shares
Class A common stock subject to possible redemption		(28,883,300)	46,960,942
Net loss
Balance	2,455,024	1,617,752	38,860,281
Additional Paid-in Capital [Member] | As Restated [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity [Line Items]
Balance	6,618,781	24,123
Issuance of Class B common stock to Sponsor			24,123
Sale of 35,000,000 Units, net of underwriting discounts and offering expenses	641,900	310,996,913	330,162,461
Sale of 8,100,000 Private Placement Warrants	195,372
Forfeiture of Founder Shares		2	2
Class A common stock subject to possible redemption	188,358	(304,402,256)	(285,918,449)
Net loss
Balance	7,644,411	6,618,781	44,267,476
Accumulated Deficit | As Previously Reported [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity [Line Items]
Balance	(2,062)	(1,000)
Sale of 35,000,000 Units, net of underwriting discounts and offering expenses
Sale of 8,100,000 Private Placement Warrants
Forfeiture of Founder Shares
Class A common stock subject to possible redemption
Net loss	(188,365)	(1,062)	(408,237)
Balance	(190,427)	(2,062)	(408,237)
Accumulated Deficit | Adjustments [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity [Line Items]
Balance	(1,618,041)
Sale of 35,000,000 Units, net of underwriting discounts and offering expenses			(25,083,100)
Sale of 8,100,000 Private Placement Warrants	(56,503)		(13,226,490)
Forfeiture of Founder Shares
Class A common stock subject to possible redemption		28,883,589
Net loss	(780,769)	(1,618,041)	(551,352)
Balance	(2,455,313)	(1,618,041)	(38,860,942)
Accumulated Deficit | As Restated [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity [Line Items]
Balance	(1,620,103)	(1,000)
Issuance of Class B common stock to Sponsor
Sale of 35,000,000 Units, net of underwriting discounts and offering expenses			(25,083,100)
Sale of 8,100,000 Private Placement Warrants	(56,503)		(13,226,490)
Forfeiture of Founder Shares
Class A common stock subject to possible redemption
Net loss	(969,134)	(1,619,103)	(959,589)
Balance	(2,645,740)	(1,620,103)	(39,269,179)
Class A Common Stock | As Previously Reported [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity [Line Items]
Balance	167
Sale of 35,000,000 Units, net of underwriting discounts and offering expenses		3,500	3,500
Forfeiture of Founder Shares
Class A common stock subject to possible redemption		(3,333)	(3,329)
Net loss	2
Balance	169	167	171
Class A Common Stock | Adjustments [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity [Line Items]
Balance	289
Sale of 35,000,000 Units, net of underwriting discounts and offering expenses
Forfeiture of Founder Shares
Class A common stock subject to possible redemption		289
Balance	289	289	661
Class A Common Stock | As Restated [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity [Line Items]
Balance	456
Issuance of Class B common stock to Sponsor
Sale of 35,000,000 Units, net of underwriting discounts and offering expenses		3,500	3,500
Sale of 8,100,000 Private Placement Warrants
Forfeiture of Founder Shares
Class A common stock subject to possible redemption		(3,004)	(2,668)
Net loss	2
Balance	458	456	832
Class B Common Stock | As Previously Reported [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity [Line Items]
Balance	875	877
Issuance of Class B common stock to Sponsor			877
Sale of 35,000,000 Units, net of underwriting discounts and offering expenses
Forfeiture of Founder Shares		(2)	(2)
Class A common stock subject to possible redemption
Balance	875	875	875
Class B Common Stock | Adjustments [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity [Line Items]
Balance
Sale of 35,000,000 Units, net of underwriting discounts and offering expenses
Forfeiture of Founder Shares
Class A common stock subject to possible redemption		28,883,300	661
Balance
Class B Common Stock | As Restated [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity [Line Items]
Balance	875	877
Issuance of Class B common stock to Sponsor			877
Sale of 35,000,000 Units, net of underwriting discounts and offering expenses
Sale of 8,100,000 Private Placement Warrants
Forfeiture of Founder Shares		(2)	(2)
Class A common stock subject to possible redemption
Balance	$ 875	$ 875	$ 875

Restatement of Previously Iss_7

Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity (Parentheticals) - shares	3 Months Ended	10 Months Ended
	Jun. 30, 2020	Dec. 31, 2020
As Previously Reported [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity (Parentheticals) [Line Items]
Sale of units	35,000,000	35,000,000
Sale of private placement units	8,100,000	8,100,000
Adjustments [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity (Parentheticals) [Line Items]
Sale of units	35,000,000	35,000,000
Sale of private placement units	8,100,000	8,100,000
As Restated [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of changes in stockholders' equity (Parentheticals) [Line Items]
Sale of units	35,000,000	35,000,000
Sale of private placement units	8,100,000	8,100,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details)	10 Months Ended
	Dec. 31, 2020USD ($)shares
Summary of Significant Accounting Policies (Details) [Line Items]
Private placement to purchase ordinary shares	25,600,000
Federal deposit insurance coverage (in Dollars) | $	$ 250,000
Class A Common Stock [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Common stock shares subject to possible redemption	33,286,067

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of calculation of basic and diluted net income (loss) per common share	10 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
As Previously Report [Member]
Numerator: Earnings allocable to Redeemable Class A Common Stock
Interest Income	$ 219,337
Income and Franchise Tax	(176,040)
Net Earnings	$ 43,297
Denominator: Weighted Average Redeemable Class A Common Stock
Redeemable Class A Common Stock, Basic and Diluted (in Shares) | shares	35,000,000
Earnings/Basic and Diluted Redeemable Class A Common Stock (in Dollars per share) | $ / shares	$ 0
Numerator: Net Loss minus Redeemable Net Earnings
Net Loss	$ (408,237)
Redeemable Net Earnings	(43,297)
Non-Redeemable Net Loss	$ (451,534)
Denominator: Weighted Average Non-Redeemable Class B Common Stock
Non-Redeemable Class B Common Stock, Basic and Diluted (in Shares) | shares	8,750,000
Loss/Basic and Diluted Non-Redeemable Class B Common Stock (in Dollars per share) | $ / shares	$ (0.05)
Adjustments [Member]
Numerator: Earnings allocable to Redeemable Class A Common Stock
Interest Income
Net Earnings
Denominator: Weighted Average Redeemable Class A Common Stock
Redeemable Class A Common Stock, Basic and Diluted (in Shares) | shares
Earnings/Basic and Diluted Redeemable Class A Common Stock (in Dollars per share) | $ / shares
Numerator: Net Loss minus Redeemable Net Earnings
Net Loss	$ (38,860,942)
Redeemable Net Earnings
Non-Redeemable Net Loss	$ (38,860,942)
Denominator: Weighted Average Non-Redeemable Class B Common Stock
Non-Redeemable Class B Common Stock, Basic and Diluted (in Shares) | shares
Loss/Basic and Diluted Non-Redeemable Class B Common Stock (in Dollars per share) | $ / shares	$ (4.44)
As Restated [Member]
Numerator: Earnings allocable to Redeemable Class A Common Stock
Interest Income	$ 219,337
Income and Franchise Tax	(176,040)
Net Earnings	$ 43,297
Denominator: Weighted Average Redeemable Class A Common Stock
Redeemable Class A Common Stock, Basic and Diluted (in Shares) | shares	35,000,000
Earnings/Basic and Diluted Redeemable Class A Common Stock (in Dollars per share) | $ / shares	$ 0
Numerator: Net Loss minus Redeemable Net Earnings
Net Loss	$ (39,269,179)
Redeemable Net Earnings	(43,297)
Non-Redeemable Net Loss	$ (39,312,476)
Denominator: Weighted Average Non-Redeemable Class B Common Stock
Non-Redeemable Class B Common Stock, Basic and Diluted (in Shares) | shares	8,750,000
Loss/Basic and Diluted Non-Redeemable Class B Common Stock (in Dollars per share) | $ / shares	$ (4.49)

Initial Public Offering (Detail

Initial Public Offering (Details) - $ / shares	1 Months Ended	10 Months Ended
	Jun. 30, 2020	Dec. 31, 2020
Over-allotment option [Member]
Initial Public Offering (Details) [Line Items]
Sale of stock in shares		35,000,000
Price per share (in Dollars per share)	$ 10	$ 10
Sale of stock in shares	4,500,000	4,500,000
Class A common stock [Member]
Initial Public Offering (Details) [Line Items]
Sale of stock in shares		35,000,000
Description of public warrant		Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8).

Private Placement (Details)

Private Placement (Details) - Private Placement [Member]	10 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Private Placement (Details) [Line Items]
Aggregate purchase of shares | shares	8,100,000
Price per shares | $ / shares	$ 1
Aggregate purchase price | $	$ 8,100,000
Class A common stock [Member]
Private Placement (Details) [Line Items]
Description of sale of stock	Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at an exercise price of $11.50 per share, subject to adjustment (see Note 8).

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Jul. 07, 2020	Mar. 10, 2020	Jun. 25, 2020	May 28, 2020	Mar. 30, 2020	Dec. 31, 2020	Jun. 30, 2020
Related Party Transactions (Details) [Line Items]
Office space secretarial administrative services			$ 10,000
Fees for the services						$ 60,000
Management fee	$ 15,000
Management fee for services						90,000
Aggregate principal amount		$ 200,000
Promissory note repaid							$ 186,165
Working capital loans						$ 1,500,000
Founder Share [Member]
Related Party Transactions (Details) [Line Items]
Sponsor payment					$ 25,000
Sale of stock (in Shares)					5,750,000
Description of stock split				the Company effected a 1:1.25 stock split with respect to the Class B common stock, on June 24, 2020, the Company effected a 1:1.20 stock split with respect to the Class B common stock and on June 25, 2020, the Company effected a 1:1.01666 stock split with respect to the Class B common stock, resulting in the Sponsor holding an aggregate of 8,768,750 Founder Shares. All share and per-share amounts have been retroactively restated to reflect the stock splits. The Founder Shares included an aggregate of up to 1,143,750 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder Shares would collectively represent approximately 20% of the Company’s issued and outstanding shares after the Initial Public Offering.
Description of founder shares				In connection with the underwriters’ partial exercise of the over-allotment option and the forfeiture of the remaining over-allotment option, 18,750 Founder Shares were forfeited and 1,125,000 Founder Shares are no longer subject to forfeiture.
Founder shares outstanding (in Shares)						8,750,000
Business combination, description						The Sponsor previously agreed pursuant to a letter agreement, dated as of June 25, 2020, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier of (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of Class A common stock for cash, securities or other property.
Founder Share [Member] | Sponsor Support Agreement [Member]
Related Party Transactions (Details) [Line Items]
Business combination, description						In addition, the Company, the Sponsor and the Insiders agreed to amend that certain letter agreement, dated as of June 25, 2020, so that the Lock-Up Period (as defined in the Sponsor Support Agreement) applicable to the Subject Securities (other than any Private Placement Warrants (as defined in the Merger Agreement)) held by the Sponsor will end on the earlier of (a) 180 days after the effective date of the Merger Agreement (the “Effective Date”) and (b) the date on which the closing price of the shares of Class A common stock of New MoneyLion is equal to or greater than $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period; provided that, for purposes of this clause (b), the measurement period for determining the closing price of the share of Class A common stock of New MoneyLion shall commence no earlier than 60 days following the Effective Date.

Commitments (Details)

Commitments (Details) - $ / shares	1 Months Ended	10 Months Ended
	Jun. 30, 2020	Dec. 31, 2020
Commitments (Details) [Line Items]
Description of underwriting agreement		The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $6,100,000 in the aggregate. In addition, the underwriters are entitled to a deferred fee of (i) 3.5% of the gross proceeds of the initial 30,500,000 Units sold in the Initial Public Offering, or $10,675,000, and (ii) 5.5% of the gross proceeds from the Units sold pursuant to the over-allotment option, or $2,475,000. Up to 10% of the deferred commission relating to the base offering may be paid at the sole discretion of the Company to third parties not participating in the Initial Public Offering (but who are members of FINRA) that assist the Company in consummating the Business Combination. The deferred fee will be forfeited by the underwriters solely in the event that the Company fails to complete a Business Combination, subject to the terms of the underwriting agreement
Option [Member]
Commitments (Details) [Line Items]
Shares of forfeited option to exercise	75,000
IPO [Member]
Commitments (Details) [Line Items]
Purchase of additional shares		4,575,000
Price per share (in Dollars per share)	$ 10	$ 10
Over-Allotment Option [Member]
Commitments (Details) [Line Items]
Shares of option to purchase of additional shares	4,500,000
Price per share (in Dollars per share)	$ 10	$ 10

Stockholders' Equity (Details)

Stockholders' Equity (Details)	10 Months Ended
	Dec. 31, 2020$ / sharesshares
Preferred stock, shares authorized	1,000,000
Preferred stock, par value (in Dollars per share) | $ / shares	$ 0.0001
Description of warrant redemption	Redemption of warrants for cash. Once the warrants become exercisable, the Company may call the warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption to each warrant holder; and ● if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like and for certain issuances of Class A common stock and equity-linked securities for capital raising purposes in connection with the closing of our initial business combination as described elsewhere in this prospectus) for any 20 trading days within a 30-trading day period ending three business days before we send to the notice of redemption to the warrant holders.
Class A Common Stock [Member]
Common stock, shares authorized	380,000,000
Common stock, par value (in Dollars per share) | $ / shares	$ 0.0001
Common stock, shares issued	8,324,377
Common stock, shares outstanding	1,711,728
Common stock shares subject to possible redemption	33,286,067
Percentage of shares converted basis	20.00%
Description of additional shares of common stock	In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), (the “Newly Issued Price”) (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
Class B Common Stock [Member]
Common stock, shares authorized	20,000,000
Common stock, par value (in Dollars per share) | $ / shares	$ 0.0001
Common stock, shares issued	8,750,000
Common stock, shares outstanding	8,750,000
Holders [Member] | Class A Common Stock [Member]
Common stock, shares issued	1,713,933
Common stock, shares outstanding	1,713,933

Income Tax (Details)

Income Tax (Details)	10 Months Ended
	Dec. 31, 2020USD ($)
Income Tax Disclosure [Abstract]
Change in the valuation allowance	$ 94,822

Income Tax (Details) - Schedule

Income Tax (Details) - Schedule of company’s net deferred tax assets	Dec. 31, 2020USD ($)
Deferred tax asset
Organizational costs/Startup expenses	$ 94,822
Total deferred tax asset	94,822
Valuation allowance	(94,822)
Deferred tax asset, net of allowance

Income Tax (Details) - Schedu_2

Income Tax (Details) - Schedule of income tax provision	10 Months Ended
	Dec. 31, 2020USD ($)
Federal
Current	$ 11,509
Deferred	(94,822)
State
Current
Deferred
Change in valuation allowance	94,822
Income tax provision	$ 11,509

Income Tax (Details) - Schedu_3

Income Tax (Details) - Schedule of reconciliation of federal income tax rate to the company’s effective tax rate	10 Months Ended
	Dec. 31, 2020
Schedule of reconciliation of federal income tax rate to the company’s effective tax rate [Abstract]
Statutory federal income tax rate	21.00%
State taxes, net of federal tax benefit	0.00%
Change in valuation allowance	(24.00%)
Income tax provision	(3.00%)

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($)	1 Months Ended		10 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2020
Fair Value Measurements (Details) [Line Items]
Percentage of business combination			20.00%
Warrants price (in Dollars per share)		$ 1.13
Fair value of public warrants	$ 19,100,000	$ 19,700,000	$ 44,800,000
Warrant value		$ 9,200,000
Cash [Member]
Fair Value Measurements (Details) [Line Items]
Assets held in Trust Account			642
US Treasury Securities [Member]
Fair Value Measurements (Details) [Line Items]
Assets held in Trust Account			$ 350,218,694
Level 3 [Member]
Fair Value Measurements (Details) [Line Items]
Percentage of business combination			20.00%
Private Placement Warrants [Member]
Fair Value Measurements (Details) [Line Items]
Private placement warrants, description	Updating the remaining inputs to the Black-Scholes option pricing model as of September 30, 2020 resulted in the private placement warrants’ fair value of $1.11 per warrant for an aggregate value of $9.0 million.		Updating the remaining inputs to the Black-Scholes option pricing model as of December 31, 2020 resulted in the private placement warrants’ fair value of $2.63 per warrant for an aggregate value of $21.3 million.
Public Warrants [Member]
Fair Value Measurements (Details) [Line Items]
Percentage of business combination			10.00%
Warrants price (in Dollars per share)		$ 1.13
Public Warrants [Member] | Level 3 [Member]
Fair Value Measurements (Details) [Line Items]
Percentage of business combination			10.00%

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis	12 Months Ended
	Dec. 31, 2020USD ($)
Level 1 [Member]
Assets:
Marketable securities held in Trust Account	$ 350,218,694
Private Placement Warrants [Member] | Level 3 [Member]
Liabilities:
Warrant Liability	21,326,510
Public Warrants [Member] | Level 1 [Member]
Liabilities:
Warrant Liability	$ 44,800,000

Subsequent Events (Details)

Subsequent Events (Details)	Feb. 11, 2021
Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Subsequent event, description	Under the Merger Agreement, the Company has agreed to acquire all of the outstanding shares of common stock of MoneyLion for $2,200,000,000 in aggregate consideration. MoneyLion stockholders will receive shares of Class A common stock of New MoneyLion (valued at $10.00 per share), and, if elected by MoneyLion, cash consideration up to the lower of (A) the amount (which may be zero) by which the Parent Closing Cash (as defined in the Merger Agreement) exceeds $260,000,000 and (B) $100,000,000, together with a contingent right to receive a pro rata portion of up to 17,500,000 shares of Class A common stock of New MoneyLion (the “Earn Out Shares”)